Targeted screening for undiagnosed diabetes reduces the number of diagnostic tests. Inter99(8)

Charlotte Glümer; T Jørgensen; Knut Borch-Johnsen

doi:10.1111/j.1464-5491.2004.01260.x

Targeted screening for undiagnosed diabetes reduces the number of diagnostic tests. Inter99(8)

Charlotte Glümer, T Jørgensen, Knut Borch-Johnsen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

17 Citationer (Scopus)

Abstract

To determine the cost and performance of a Danish risk score, fasting plasma glucose (FPG), and HbA1c as single screening tests and in combination with targeted screening.

Originalsprog	Engelsk
Tidsskrift	Diabetic Medicine
Vol/bind	21
Udgave nummer	8
Sider (fra-til)	874-80
Antal sider	7
ISSN	0742-3071
DOI	https://doi.org/10.1111/j.1464-5491.2004.01260.x
Status	Udgivet - aug. 2004
Udgivet eksternt	Ja

Adgang til dokumentet

10.1111/j.1464-5491.2004.01260.x

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

@article{a2b21f334aa14700955b561089bfc40e,

title = "Targeted screening for undiagnosed diabetes reduces the number of diagnostic tests. Inter99(8)",

abstract = "To determine the cost and performance of a Danish risk score, fasting plasma glucose (FPG), and HbA1c as single screening tests and in combination with targeted screening.",

author = "Charlotte Gl{\"u}mer and T J{\o}rgensen and Knut Borch-Johnsen",

year = "2004",

month = aug,

doi = "10.1111/j.1464-5491.2004.01260.x",

language = "English",

volume = "21",

pages = "874--80",

journal = "Diabetic Medicine",

issn = "0742-3071",

publisher = "Wiley-Blackwell",

number = "8",

}

TY - JOUR

T1 - Targeted screening for undiagnosed diabetes reduces the number of diagnostic tests. Inter99(8)

AU - Glümer, Charlotte

AU - Jørgensen, T

AU - Borch-Johnsen, Knut

PY - 2004/8

Y1 - 2004/8

N2 - To determine the cost and performance of a Danish risk score, fasting plasma glucose (FPG), and HbA1c as single screening tests and in combination with targeted screening.

AB - To determine the cost and performance of a Danish risk score, fasting plasma glucose (FPG), and HbA1c as single screening tests and in combination with targeted screening.

U2 - 10.1111/j.1464-5491.2004.01260.x

DO - 10.1111/j.1464-5491.2004.01260.x

M3 - Journal article

C2 - 15270791

SN - 0742-3071

VL - 21

SP - 874

EP - 880

JO - Diabetic Medicine

JF - Diabetic Medicine

IS - 8

ER -

Targeted screening for undiagnosed diabetes reduces the number of diagnostic tests. Inter99(8)

Abstract

Adgang til dokumentet

AUB Link

Fingeraftryk

Citationsformater